"New Neural Biomarker Discovered for OCD"

Researchers at Baylor College of Medicine have identified a neural activity pattern that can predict and monitor the clinical status of OCD patients undergoing deep brain stimulation (DBS). This biomarker can guide DBS therapy, improving treatment outcomes for severe, treatment-resistant OCD, and may have broader implications for other neuropsychiatric disorders.